Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹6.71Admitted-Finance | ₹6.71 | L1 | Admitted-Finance |
| 2 | L2₹354.58Admitted-Finance | ₹354.58 | L2 | Admitted-Finance |
| 3 | L3₹404.25Admitted-Finance | ₹404.25 | L3 | Admitted-Finance |
| 4 | L4₹460.82Admitted-Finance | ₹460.82 | L4 | Admitted-Finance |
| 5 | L5₹1.8 LAdmitted-Finance 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | ₹1.8 L | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | medopharm L3 | Novartis Healthcare Pvt Ltd L6 | Novo Nordisk India Private Limited L5 | ZEE LABORATORIES LTD. L4 | MEDIPOL PHARMACEUTICAL INDIA PVT LTD L1 | SCOTT-EDIL PHARMACIA LTD. L2 |
|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Zinc Sulphate Dispersible Tablets IP Elemental Zinc 10 mg [472 | 67,33,46,972 | 10x10 Tab Strip/ Blister (Rate should be quoted for 100 Tab) | - | - | - | - | - | - |
| 2.00 | Cefixime Oral Suspension IP 25mg/ml (Paediatric Drops) [511] | 85,49,206 | 10 ml Bottle (with a seperate dropper, which should be able to screw & cap the bottle) in a unit carton (Rate should be quoted for Single unit) | - | - | - | 9.88 ₹10.37 Lowest | - | - |
| 3.00 | Recombinant Coagulation Factor VIIa 1mg [690] | 10,464 | Vial (Rate Should be quoted for Single Unit) | - | - | 38,027 ₹38,027 Lowest | - | - | - |
| 4.00 | Iron and Folic Acid Syrup IP Each ml of Syrup contains Ferrous Sulphate IP Equivalent to elemental ferrous iron 20mg, Folic Acid IP 0.1mg with any flavour [448W] | 3,13,47,720 | 50ml Bottle (Amber Colour) with Auto dispenser to dispense 1ml each time,Packed in a unit carton (Rate should be quoted for Single unit) | - | - | - | - | 6.39 ₹6.71 Lowest | - |
| 5.00 | Azithromycin Tablets IP 250mg [79A] | 9,96,04,566 | 10X3X3 Tab strip/Blister(strip/blister of 3 tab) (Rate Should be quoted for 90 Tab.) | 385 ₹404.25 | - | - | 429 ₹450.45 | - | 337.7 ₹354.58 Lowest |
| 6.00 | Ceftriaxone 1000mg and Salbactum 500mg and Disodium Edetate 37mg Inj [NRD-185] | 5,71,506 | vial / Amp (Rate should be quoted Single Unit) | - | - | - | - | - | - |
| 7.00 | Durvalumab 120 mg Inj. [NRD-222] | 1,824 | vial / Amp (Rate should be quoted Single Unit) | - | - | - | - | - | - |
| 8.00 | Durvalumab 500mg Inj. [NRD-223] | 2,624 | vial / Amp (Rate Should be quoted for Single vial / Amp ) | - | - | - | - | - | - |
| 9.00 | Insulin Aspart 100IU/ml Injection 3 ml [NRD-258] | 1,72,800 | Vial / Pre Filled Pen / Pen alongwith 03 Cartridge and 05 needles (Rate should be quoted Single Unit) | - | - | 845 ₹887.25 Lowest | - | - | - |
| 10.00 | Ruxolitinib 5 mg Tablet / Capsule [NRD-772] | 36,800 | 10x10 (Rate Should be quoted for 100 Tab/cap) | - | 1,45,000 ₹1,52,250 Lowest | - | - | - | - |
Tender Value
₹371.9 Cr
EMD Value
₹7.4 Cr
Closing Date
29 Oct 2025, 6:00 pmClosed
MD RMSCL
Rajasthan Medical Services Corporation Limited, Gandhi Block, Swasthya Bhawan, Tilak Marg, CScheme, Jaipur-302005 (Raj.)
E-BID FOR RATE CONTRACT CUM SUPPLY AND EMPANELMENT OF FIRMS FOR DRUGS AND MEDICINES
2025_RMSCL_501398_1
RMSCL/PROC/DRUG/NIB-09/25/1970 Dt.15.09.2025
Open Tender
Supply of Materials/Hiring of Goods
Item Rate
60 days
All Rajasthan
As Per Bid Document
4 documents required · 4 mandatory
₹2,360
Secretary, RREIS
₹7.4 Cr
Yes
RMSCL Board Room
10 Apr 2026
15 Sept 2025
30 Oct 2025
15 Sept 2025
29 Oct 2025
5 Oct 2025
19 Sept 2025
stage.html
html • 0.05 MB
technical_893512.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.25 MB
NIB09.pdf
Tender Documents • 32.64 MB
BOQ_893512.xls
BOQ • 0.31 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].